All articles by  

  1. Sanofi-Lexicon diabetes drug gets split verdict from FDA panel

    Sanofi and Lexicon Pharmaceuticals have received split decision from an advisory panel to the US Food and Drug Administration (FDA)…
    Read More…

    18 Jan
  2. Acrotech Biopharma to buy seven drugs from Spectrum for $300m

    Aurobindo Pharma USA subsidiary Acrotech Biopharma has signed a definitive agreement to buy seven haematology and oncology drugs from Spectrum…
    Read More…

    18 Jan
  3. Proteus Digital Health introduces digital medicines for cancer

    In collaboration with Fairview Health Services and University of Minnesota Health in the US, Proteus Digital Health has launched digital…
    Read More…

    18 Jan
  4. Teva secures US regulatory approval for generic version of Sabril

    Teva Pharmaceuticals USA has secured approval from the US Food and Drug Administration (FDA) for its generic version of Sabril…
    Read More…

    17 Jan
  5. European and UK pharma industry call for action as parliament rejects Brexit deal

    The European and UK pharma industry have called for preparations to ensure that patients will have access to their medications…
    Read More…

    17 Jan
  6. AstraZeneca licences Luye Pharma cholesterol drug in China

    Luye Pharma has granted AstraZeneca’s Chinese division exclusive rights to promote its cholesterol medicine Xuezhikang Capsules in mainland China. The…
    Read More…

    17 Jan
  7. US Oversight Committee launches drug price probe into major companies

    The US Committee on Oversight and Reform chairman Elijah Cummings has launched an investigation into the drug pricing practices of…
    Read More…

    16 Jan
  8. Eisai and Purdue Pharma seek US approval for lemborexant to treat insomnia

    Eisai and its partner Purdue Pharma have submitted new drug application to the US Food and Drug Administration (FDA) seeking…
    Read More…

    16 Jan
  9. Sanofi and Biomunex partner to develop antibody therapeutics

    Sanofi has signed a licensing agreement with French biopharmaceutical firm Biomunex Pharmaceuticals for the development of antibody-based drugs. As part…
    Read More…

    16 Jan
  10. Ascletis Pharma to develop Alphamab’s viral diseases drug in China

    Ascletis Pharma has signed an exclusive licensing agreement with Suzhou Alphamab to develop an investigational candidate, KN035, for the treatment…
    Read More…

    15 Jan

Go Top